Anti-PD-L1 [10F.9G2]

Absolute Antibody

Anti-PD-L1 [10F.9G2]

7

The specificity of this antibody has been confirmed in ELISA analysis (Eppihimer et al, 2002). This antibody reacts specifically with mPD-L1-transfected cells in flow cytometry, and has been used to assess microvascular endothelial cells PD-L1 expression (Eppihimer et al, 2002). When administered to mice, a radiolabelled version of this antibody has been used to quantify PD-L1 expression in vivo, by measuring antibody accumulation in different tissues (Eppihimer et al, 2002). This antibody has also been used in immunohistochemical analysis of PD-L1 expression in frozen tissue sections of murine brain (Eppihimer et al, 2002) and murine hearts (Rodig et al, 2003). This antibody has been shown to block the binding of PD-L1 to both PD-1 and B7-1 (Paterson et al, 2011). This antibody precipitates diabetes in NOD mice and in adoptive transfer models of CD4+ and CD8+ T cell-driven diabetes, and accelerates diabetes in recipients of T cells from diabetic and prediabetic mice (Paterson et al, 2011).

Flow Cytometry, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking

ELISA; FC; IHC; blocking

Research Use Only

Programmed cell death 1 ligand 1

This is a bispecific, knob-into-hole heterodimerized antibody, with one arm directed against mouse PD-L1 (Fab) and one arm directed against mouse CD3e (scFv).

-20°C,2°C to 8°C

12352203